PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Sep-2022 Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer Tiziana Life Sciences
09-Sep-2022 Dupixent® (dupilumab) late-breaking Phase 3 data at EADV 2022 showed significant improvements in signs and symptoms of prurigo nodularis Sanofi
09-Sep-2022 Teva announces new positive AJOVY®▼ (fremanezumab) real world data from its migraine prevention study, PEARL and welcomes updated European Headache Federation guidelines on the use of CGRP mAbs Teva Pharmaceuticals
09-Sep-2022 Medacta Group SA reports strong revenue growth of 19.0% and adjusted EBITDA margin of 27.5% in the first semester 2022 Medacta Group SA
08-Sep-2022 MIMETAS Appoints Dhaval Patel as Chair of the Board of Directors B3C newswire
08-Sep-2022 Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day Moderna, Inc.
08-Sep-2022 Baxter Expands Historically Black Colleges and Universities Partnerships, Funding Commitments to Further the Pipeline of Black Healthcare Professionals Baxter
07-Sep-2022 ProBioGen and City of Hope Announce Commercial License Agreement to Use AGE1.CR.pIX® Vaccine Manufacturing Platform for Cytomegalovirus (CMV) Vaccine B3C newswire
07-Sep-2022 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
07-Sep-2022 iOmx Therapeutics appoints Professor Frances Balkwill to the Scientific Advisory Board iOmx Therapeutics AG
07-Sep-2022 Cellbox Solutions Expands to Israeli Market Via Partnership with BioGate Ltd. B3C newswire
07-Sep-2022 Cannovum AG: Record sales and new customers in the first half of 2022 Cannovum AG
07-Sep-2022 Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry Gerresheimer AG
07-Sep-2022 Biophytis announces very promising top line results of its phase 2-3 COVA clinical study in COVID-19-related respiratory failure Biophytis
07-Sep-2022 Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall Dermapharm Holding SE
07-Sep-2022 Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference Relief Therapeutics Holding SA
06-Sep-2022 Zymeworks Announces Release Of ESMO Abstract For Phase 1 Study Of Zanidatamab Zovodotin (ZW49) In Solid Cancers Zymeworks
06-Sep-2022 The 2022 International Pharma Logistics Masterclass brings to Abu Dhabi 120 industry experts, academics, and policymakers from 21 countries Pharma.Aero
06-Sep-2022 New analyses in real-world setting support the effectiveness of Fasenra in severe eosinophilic asthma AstraZeneca
06-Sep-2022 Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU Pleco Therapeutics